PROTECTING HEALTH DATA ON PUBLIC CLOUD WITH HOSTEUR & CYSEC

Cysec

October, 2021 – HOSTEUR concluded a strategic partnership with CYSEC to guarantee the high security level for its customers’ critical data. The cloud hosting provider has selected CYSEC for the provisioning of natively encrypted Kubernetes clusters. Thanks to this partnership, HOSTEUR’s end customers will be able to benefit from an optimal confidentiality while profiting from the …

PROTECTING HEALTH DATA ON PUBLIC CLOUD WITH HOSTEUR & CYSEC Read More »

whats is confidencial computing CYSEC

Cysec

October, 2021 – HOSTEUR concluded a strategic partnership with CYSEC to guarantee the high security level for its customers’ critical data. The cloud hosting provider has selected CYSEC for the provisioning of natively encrypted Kubernetes clusters. Thanks to this partnership, HOSTEUR’s end customers will be able to benefit from an optimal confidentiality while profiting from the …

whats is confidencial computing CYSEC Read More »

For Immediate Release

Transmutex

BANK OF ABYSSINIA CHOOSES NETGUARDIANS TO STRENGTHEN ITS FIGHT AGAINST FRAUD Yverdon-les-Bains, 25 September, 2021: Award-winning Swiss FinTech NetGuardians, renowned for its enterprise risk platform for combatting bank fraud, announced it has been selected by Bank of Abyssinia to further enhance fraud prevention. With more than 5.5 million customers, Abyssinia is one of Ethiopia’s largest banks …

For Immediate Release Read More »

AIFinTech100 2021

NetGuardians

NetGuardians is selected as one of the world’s most innovative AI solution providers for financial services selected by a panel of industry experts and analysts. The AIFINTECH100 is an annual list of 100 of the world’s most innovative AI solution providers for financial services selected by a panel of industry experts and analysts. These are …

AIFinTech100 2021 Read More »

Representative vendor in Aite’s report on Fraud and AML Machine Learning Platforms: Financial Crime Detection’s Next Frontier

NetGuardians

NetGuardians is selected as one of the world’s most innovative AI solution providers for financial services selected by a panel of industry experts and analysts. The AIFINTECH100 is an annual list of 100 of the world’s most innovative AI solution providers for financial services selected by a panel of industry experts and analysts. These are …

Representative vendor in Aite’s report on Fraud and AML Machine Learning Platforms: Financial Crime Detection’s Next Frontier Read More »

Publication of our review on the Heterogeneity in Fragile X Syndrome

Stalicla

We are very pleased to announce the publication of our review on the Heterogeneity in Fragile X Syndrome (FXS) issued in Frontiers in Psychiatry. This article was written within the scope of the recent collaboration between STALICLA DDS in Barcelona and DDU in Geneva.It highlights the need for precision medicine-based treatments in neurodevelopmental disorders, with …

Publication of our review on the Heterogeneity in Fragile X Syndrome Read More »

STALICLA featured in swiss magazine PME

Stalicla

Dix jeunes pousses suisses intègrent le premier programme Venture Leaders dédié au secteur des biotechnologies et iront cet automne à la rencontre d’investisseurs internationaux et des leaders du secteur. Parmi ces start-up sélectionnées, notamment, par Venturelab et Swissnex, trois romandes: Alithea Genomics, Gnubiotics Sciences et Stalicla. READ MORE

STALICLA at MedInvest – Neurological Diseases & Mental Health Disorders Conference

Stalicla

Geneva, Switzerland, September 8, 2021 — STALICLA, a Swiss clinical-stage biotech company advancing precision medicine to patients with Autism Spectrum Disorders and other Neurodevelopmental Disorders, announced today that its CEO and Founder, Lynn Durham, will present at the THE NEUROLOGICAL DISEASES & MENTAL HEALTH DISORDERS CONFERENCE, on September 9, 2021. Ms Durham’s presentation will take …

STALICLA at MedInvest – Neurological Diseases & Mental Health Disorders Conference Read More »

STALICLA at Swiss Biotech Day 2021

Stalicla

STALICLA, a Swiss clinical-stage biotech company advancing precision medicine to patients with Autism Spectrum Disorders and other Neurodevelopmental Disorders, announced today that its CEO and Founder, Lynn Durham, will present at the Swiss Biotech Day, on September 7, 2021 at the Congress Center in Basel – Switzerland. STALICLA’s presentation will take place within the Emerging …

STALICLA at Swiss Biotech Day 2021 Read More »